Article
Paul Ehrlich's magic bullet concept: 100 years of progress.
Nature reviews. Cancer - 1 Jun 2008
Strebhardt Klaus, Ullrich Axel
Abstract excerpt
Exceptional advances in molecular biology and genetic research have expedited cancer drug development tremendously. The declared paradigm is the development of 'personalized and tailored drugs' that precisely target the specific molecular defects of a cancer patient. It is therefore appropriate to revisit the intellectual foundations of the development of such agents, as many have shown great clinical success....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
